First- vs second-generation antipsychotic drugs in schizophrenia

被引:2
|
作者
Andrade, Chittaranjan [1 ]
Kharawala, Saifuddin [1 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat, La Canada Flintridge, CA 91011 USA
关键词
D O I
10.1001/archpsyc.64.8.978-b
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:978 / 979
页数:2
相关论文
共 50 条
  • [21] Akathisia and second-generation antipsychotic drugs
    Kumar, R.
    Sachdev, P.
    [J]. MOVEMENT DISORDERS, 2009, 24 : S67 - S67
  • [22] Akathisia and second-generation antipsychotic drugs
    Kumar, R.
    Sachdev, P. S.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 : S122 - S122
  • [23] Comparing Acute Toxicity of First- and Second-Generation Antipsychotic Drugs: A 10-Year, Retrospective Cohort Study
    Ciranni, Michael A.
    Kearney, Thomas E.
    Olson, Kent R.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (01) : 122 - 129
  • [24] First- and second-generation perfluorocarbon emulsions
    Vorob'ev, S. I.
    [J]. PHARMACEUTICAL CHEMISTRY JOURNAL, 2009, 43 (04) : 209 - 218
  • [25] Formation of the first- and second-generation stars
    Omukai, Kazuyuki
    [J]. STELLAR EVOLUTION AT LOW METALLICITY: MASS LOSS, EXPLOSIONS, COSMOLOGY, 2006, 353 : 263 - 270
  • [26] First- and second-generation perfluorocarbon emulsions
    S. I. Vorob’ev
    [J]. Pharmaceutical Chemistry Journal, 2009, 43 : 209 - 218
  • [27] Hip fractures in users of first- vs. second-generation bisphosphonates
    Mamdani, M.
    Kopp, A.
    Hawker, G.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2007, 18 (12) : 1595 - 1600
  • [28] Hip fractures in users of first- vs. second-generation bisphosphonates
    M. Mamdani
    A. Kopp
    G. Hawker
    [J]. Osteoporosis International, 2007, 18 : 1595 - 1600
  • [29] Second-generation antipsychotic medication combinations for schizophrenia
    Eisen, Carol
    Shaner, Roderick
    Unutzer, Jurgen
    Fink, Arlene
    Wells, Kenneth B.
    [J]. PSYCHIATRIC SERVICES, 2008, 59 (03) : 235 - 235
  • [30] Determinants of first- and second-generation antipsychotic drug use in clinically unstable patients with schizophrenia treated in four European countries
    Barbui, C
    Nosè, M
    Mazzi, MA
    Bindman, J
    Leese, M
    Schene, A
    Becker, T
    Angermeyer, MC
    Koeter, M
    Gray, R
    Tansella, M
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2006, 21 (02) : 73 - 79